ResultsCX Earns Industry Honors Across Cybersecurity, Leadership, Culture, and Innovation

Global healthcare AI experts and former UK Health Minister back AI that detects healthcare-associated infections up to 72 hours earlier

LabConnect Deploys Sapio LIMS Across Global Operations

LabConnect has officially completed the global deployment of LIMSConnect, its internal name for the enterprise-wide implementation of Sapio LIMS, across more than 30 locations on six continents. Built on Sapio’s configurable, AI-enabled lab informatics platform, LIMSConnect unifies complex sample workflows, improves data integrity, and enables scalable innovation across LabConnect’s central laboratory network.

FDB Launches Meducation® Bedside Solution to Empower Nurses & Streamline First-Dose Patient Medication Education in Hospitals

Accessible, patient-focused & CMS-required medication instructions save nurses time during inpatient care, while improving HCAHPS scores for patient satisfaction

Biocair Announces Rapid APAC Expansion with New Office in Shanghai

Biocair, an established global leader in life science logistics, announced the further expansion of its operations in the APAC region with the opening of a new office in Shanghai, China.

Alfa Chemistry Unveils Food Surfactants to Advance Modern Food Manufacturing

Alfa Chemistry has launched a new portfolio of food surfactants designed to improve stability, texture, and processing efficiency in modern food manufacturing, supporting clean-label and plant-based formulation trends.

VieCure Expands Community Oncology Care Network with Addition of Summit Cancer Centers

VieCure adds Summit Cancer Centers to community oncology care network.

Arcinova Appoints Christian Dowdeswell as New Managing Director

Supreme Group Acquires Pivot Design, Marking a Significant Expansion in Pharma and Rare Disease

Supreme Group Acquires Pivot Design, Marking a Significant Expansion in Pharma and Rare Disease

MetaVia Announces AI-Driven Collaboration with Syntekabio to Explore Additional Indications for DA-1241

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a research collaboration with Syntekabio, Inc., a leading artificial intelligence (AI)-driven drug discovery company, to identify additional disease targets and optimize the therapeutic profile of DA-1241, MetaVia’s novel oral G-Protein-Coupled Receptor 119 (GPR119) agonist.

Antibodies.com expands UK headquarters with new 5x larger facilities in Cambridge to accommodate rapid growth

• Investment in premises on Cambridge Technopark reflects significant milestone in the Company’s growth • Relocation increases logistics and R&D capacity, enabling faster customization and turnaround, strengthening order fulfilment to better support customers in their research and development efforts

Roche's first respiratory test powered by TAGS technology receives FDA clearance for SARS-CoV-2, Influenza A, Influenza B and RSV

Advarra appoints Brian Hart as Chief Technology Officer

Former Covera Health CTO to lead technology and product strategy at Advarra, driving innovation in clinical research

New Research Illustrates Gaps in COPD Care and the Need for Better Patient-Provider Communication

New research from the COPD Foundation and Phreesia shows patients with chronic obstructive pulmonary disease (COPD) face significant challenges, but conversations with healthcare providers can play a critical role in helping patients understand their condition, set realistic goals, ease symptom burden and improve their quality of life.

InSysBio to launch Immune Response Template Open for QSP modeling

InSysBio announces Immune Response Template (IRT) which was previously available under a license model now is completely free to use. IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system.

AppOmni Launches New SaaS and AI Security Packages to Tackle Rising Risks

I wanted to share that Software-as-a-Service (SaaS) security leader, AppOmni today announced new innovations to combat rising AI and SaaS risks for healthcare companies: https://appomni.com/press-releases/saas-ai-security-innovation Please let me know if you’d like to speak with them for more about the benefits for healthcare, get a product image, or if I can provide anything further. The rapid adoption of AI has introduced a new and complex attack surface that healthcare cybersecurity teams must manage. AI is an active participant in the SaaS environment; whether embedded in SaaS platforms (such as M365 or Google Workspace) or acting as agents, AI tools constantly access and process sensitive data across the SaaS estate. Healthcare organizations need the ability to identify unsanctioned or shadow AI and SaaS usage, as well as practical strategies to control and monitor AI usage. AppOmni is defining the future of SaaS and AI security by arming organizations of all sizes with the end-to-end controls needed for safe usage of these applications, helping them identify critical risks, protect sensitive data, detect abnormal behavior, and respond to evolving threats. The new features help healthcare understand their risk exposure to AI and implement controls to secure them by identifying both sanctioned and unsanctioned/ shadow AI apps, including AI embedded within SaaS applications. It’s also adding support for 30 new AI and SaaS applications, including ChatGPT Enterprise, Claude, OpenAI, and Anthropic, Cisco Umbrella, Cisco Secure Access, and Gong. And it’s giving healthcare organizations a free 90-day trial of its new AppOmni Foundations package – a SaaS security starter solution for organizations that need to discover shadow SaaS and AI, app users and permission, and detect threats and anomalous activities.

iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions

iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions

Clearwater Launches New Enterprise Cyber Risk Management Solution to Help Healthcare Organizations Reduce Cyber Risk, Strengthen Compliance, and Drive Boardroom Confidence

Clinisys Acquires Orchard Software

Clinisys announces the acquisition of Orchard Software from Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses. The acquisition brings together two leaders in the LIS market and reaffirms Clinisys’s continued commitment to provide the laboratory informatics marketplace with cutting edge software advancements.

Symbiosis Reaches Major Milestone with 1,000th Batch of Injectable Drug Product